Feed / ARDT

Ardent Health, Inc.

ARDT

Healthcare · 11.00 -1.3% today

Isolated · not yet confirmedMarket checked 11 Sept, 14:05 GMT-4

Market read

Ardent Health, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 10 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.

Company-1.3% todayVolume comparison unavailable
Market group0 of 10 activeAuto & Communication Services · unavailable
Disclosed network0 of 5 confirmingNo filing-linked name is confirming now
What would change this read
  • ARDT's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if ARDT's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Medical Care Facilities

No new filing conclusion is available. 0 of 10 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • ARDT's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 11, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods4
Price observations319
Usable filing statements148
Verified relationships5
Evidence supporting the case
  • Latest annual revenue changed +6.0% year over year.
  • Operating cash flow covered net income at 3.46x in the latest annual period.
  • Macroeconomic conditions has repeated favorable evidence across 4 filings.
Evidence challenging the case
  • Net margin changed -1.4 percentage points in the latest annual period.
  • Diluted shares increased 6.6% in the latest annual period.
  • Credit and interest rates has repeated adverse evidence across 3 filings.
Questions before a position
  • P/E is 48% below the available filing-peer median; determine whether growth and quality justify the difference.
  • EV/sales is 81% below the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Sep 10, 2026

10.89
6m+15.9%12m-14.4%24m
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2022-12-31$5.1B$1.50
2023-12-31$5.4B+5.5%$0.43+0.0%
2024-12-31$6.0B+10.3%$1.58+5.3%
2025-12-31$6.3B+6.0%$0.96+6.6%

What management says matters

Persistent and emerging business drivers

Macroeconomic conditionspositive · 4 filings
Third party providers of hospital-based physicians, including those with whom we contract, have experienced significant disruption in the form of regulatory changes, including those stemming from enactment of the No Surprises Act, challenging labor market con…
10-Q · May 6, 2026
Credit and interest ratesnegative · 3 filings
During the year ended December 31, 2024, the Company released its liability for unrecognized tax benefits, as well as the accrued interest expense related to the unrecognized tax benefits, due to the expiration of its statute of limitations.
10-K · Mar 16, 2026
Restructuring and cost reductionsmixed · 3 filings
We also expect these reforms to ACA marketplace exchange-based plans to adversely impact results in 2026, partially offset by our ongoing resiliency and cost reduction initiatives.
10-Q · May 6, 2026
Supply chain and availabilitymixed · 2 filings
The decrease in supplies as a percentage of total revenue was primarily attributable to an increase in revenue from Medicaid supplemental payment programs compared to the same prior year period and ongoing supply chain initiatives.
10-Q · May 6, 2026

Valuation discipline

Descriptive valuation snapshot

Price/sales 0.2× · EV/sales 0.3×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

11.00-1.3% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 14:05 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for ARDT. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for ARDT. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind ARDT

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

VTRVentas, Inc.distributorMay 6, 2026

Rents and leases, related party — Rents and leases, related party, consisted of lease expense related to the Ventas Master Lease and other lease agreements with Ventas for certain medical office buildings.

VTRVentas, Inc.partnerMar 16, 2026

Ventas Master Lease Effective August 4, 2015, we sold the real property for ten of our hospitals to Ventas, which is a related party as, prior to our IPO, it was a common unit holder of Ardent Health Partners, LLC and owned shares of common stock of AHP Healt…

Depended on by

VTRVentas, Inc.investeeApr 28, 2026

Our investments in unconsolidated entities also includes investments in operating entities, such as Ardent Health, Inc.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

ARDT is currently a Early Follower in the organic co-movement group Auto & Communication Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for ARDT; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.